The management of patients with lobular carcinoma in situ of the breast.

The management of patients with lobular carcinoma in situ (LCIS) has been an enigma for almost as long as the entity has been known. Continued follow-up of these patients has documented that about a quarter to a third will subsequently develop carcinoma in either breast after diagnostic excision, but no further therapy. Lobular carcinoma in situ has a 60… CONTINUE READING